StreetInsider.com News Articles

Ainos signs VELDONA license deal with BioPhoenix worth up to $10M

Thu, 24 Sep 2026 08:02:32 -0400

Ainos, Inc. (NASDAQ: AIMD, NASDAQ: AIMDW) has entered into a license agreement with BioPhoenix Co., Ltd. for its VELDONA platform, establishing a collaboration framework with a potential aggregate value of $10 million, according to a company statement.

Under the agreement, BioPhoenix receives an exclusive worldwide license to VELDONA for two initial indications — Sjögren's disease and thrombocytopenia — covering research, development, manufacturing, regulatory activities and commercialization. The $10 million framework includes an initial license fee, conditional consideration for licenses covering 15 additional indications, and a one-time fee triggered by BioPhoenix's first sublicense to a third party.

The company noted that the $10

Ainos signs VELDONA license deal with BioPhoenix worth up to $10M

Thu, 24 Sep 2026 08:02:32 -0400

The company noted that the $10

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

Thu, 24 Sep 2026 08:00:00 -0400

HOUSTON, TX / ACCESS Newswire / September 24, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has entered into a VELDONA^® License Agreement with BioPhoenix Co., Ltd. ("BioPhoenix"), establishing a collaboration framework with a potential aggregate value of $10 million. The framework comprises an initial license fee, conditional consideration for licenses covering 15 additional indications, and a one-time fee upon the first sublicense.

The agreement marks a significant milestone for VELDONA by establishing a partner-funded development model. BioPhoenix will assume primary funding and execution responsibilities for

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

Thu, 24 Sep 2026 08:00:00 -0400

The agreement marks a significant milestone for VELDONA by establishing a partner-funded development model. BioPhoenix will assume primary funding and execution responsibilities for

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

Thu, 24 Sep 2026 08:00:00 -0400

The agreement marks a significant milestone for VELDONA by establishing a partner-funded development model. BioPhoenix will assume primary funding and execution responsibilities for

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

Thu, 24 Sep 2026 08:00:00 -0400

The agreement marks a significant milestone for VELDONA by establishing a partner-funded development model. BioPhoenix will assume primary funding and execution responsibilities for

Ainos receives initial orders for AI Nose in semiconductor manufacturing

Mon, 14 Sep 2026 08:01:41 -0400

Ainos, Inc. (NASDAQ: AIMD, NASDAQ: AIMDW) announced it is receiving initial commercial orders for its second-generation AI Nose platform from a front-end semiconductor manufacturer, following a validation program involving approximately 200 systems deployed earlier in 2026.

The company launched the second-generation AI Nose platform in August 2026, with upgrades to software, firmware, edge AI, hardware reliability, modular design, over-the-air capabilities, and fleet management. The platform is designed for continuous operation in industrial environments.

Ainos also reported that its proprietary real-world chemical dataset has surpassed 1 billion records, up from approximately 878 million records reported in August 2026. The dataset is generated by

Ainos receives initial orders for AI Nose in semiconductor manufacturing

Mon, 14 Sep 2026 08:01:41 -0400

Ainos also reported that its proprietary real-world chemical dataset has surpassed 1 billion records, up from approximately 878 million records reported in August 2026. The dataset is generated by

Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing

Mon, 14 Sep 2026 08:00:00 -0400

Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026

Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation

HOUSTON, TX / ACCESS Newswire / September 14, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its second-generation AI Nose platform is advancing into commercial deployment in front-end semiconductor manufacturing, building on validation activities initiated earlier this year involving approximately 200 AI Nose systems. Ainos is receiving initial commercial orders from a front-end semiconductor company.

The milestone marks Ainos' progress

Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing

Mon, 14 Sep 2026 08:00:00 -0400

Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026

Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation

The milestone marks Ainos' progress

Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing

Mon, 14 Sep 2026 08:00:00 -0400

Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026

Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation

The milestone marks Ainos' progress

Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing

Mon, 14 Sep 2026 08:00:00 -0400

Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026

Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation

The milestone marks Ainos' progress

Ainos granted three Japanese patents for electronic nose in robotics

Wed, 09 Sep 2026 08:03:10 -0400

Ainos, Inc. (NASDAQ: AIMD, NASDAQ: AIMDW) announced it has received three new patents in Japan covering AI Nose technologies and their integration with robotic systems, according to a company press release.

The three patents cover gas exchange systems for electronic noses, rapid chemical detection, and the integration of electronic nose technology with robots.

With the additions, Ainos reports a total of 124 patent assets worldwide, spanning chips, sensing architectures, chemical molecules, and applications.

The company states it does not intend to manufacture robots, but rather develop chemical sensing technology that could be used as a component layer within robotic and autonomous machine systems.

"Cameras

Ainos granted three Japanese patents for electronic nose in robotics

Wed, 09 Sep 2026 08:03:10 -0400

The three patents cover gas exchange systems for electronic noses, rapid chemical detection, and the integration of electronic nose technology with robots.

With the additions, Ainos reports a total of 124 patent assets worldwide, spanning chips, sensing architectures, chemical molecules, and applications.

The company states it does not intend to manufacture robots, but rather develop chemical sensing technology that could be used as a component layer within robotic and autonomous machine systems.

"Cameras

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

Wed, 09 Sep 2026 08:00:00 -0400

New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applications

HOUSTON, TX / ACCESS Newswire / September 9, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems.

The newly granted patents cover gas exchange, rapid chemical detection and electronic nose integration with robots:

Electronic nose with gas exchange system and robot equipped with electronic nose
Electronic nose and robot capable

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

Wed, 09 Sep 2026 08:00:00 -0400

The newly granted patents cover gas exchange, rapid chemical detection and electronic nose integration with robots:

Electronic nose with gas exchange system and robot equipped with electronic nose
Electronic nose and robot capable

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

Wed, 09 Sep 2026 08:00:00 -0400

The newly granted patents cover gas exchange, rapid chemical detection and electronic nose integration with robots:

Electronic nose with gas exchange system and robot equipped with electronic nose
Electronic nose and robot capable

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

Wed, 09 Sep 2026 08:00:00 -0400

The newly granted patents cover gas exchange, rapid chemical detection and electronic nose integration with robots:

Electronic nose with gas exchange system and robot equipped with electronic nose
Electronic nose and robot capable

Ainos launches on-site nitrogen generator for AI and chip facilities

Wed, 19 Aug 2026 09:01:18 -0400

Ainos, Inc. (NASDAQ: AIMD)(NASDAQ: AIMDW) announced the global launch of its Atmosphere Engine platform, a system designed to generate high-purity nitrogen and oxygen directly from ambient air at the point of use.

The company said the platform uses electrochemical air-separation technology and, based on its current engineering calculations, is designed to require approximately one-third of the electricity consumed by conventional molecular sieve-based systems under comparable operating conditions.

Ainos said it is initially targeting AI servers, high-density computing infrastructure and semiconductor manufacturing facilities. The platform is designed to create nitrogen-rich inert environments intended to reduce oxidation and environmental degradation around high-value equipment.

The system

Ainos launches on-site nitrogen generator for AI and chip facilities

Wed, 19 Aug 2026 09:01:18 -0400

The system

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Wed, 19 Aug 2026 09:00:00 -0400

High-efficiency, on-site nitrogen generation is designed to protect high-value AI infrastructure, reduce oxidation and environmental degradation, and bring greater flexibility and resilience to semiconductor manufacturing

HOUSTON, TX / ACCESS Newswire / August 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the global launch of Atmosphere Engine^™, a new platform that extends the Company's capabilities in AI-powered environmental sensing, Chemical Intelligence and smart manufacturing into active environmental management.

Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the point of use.

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Wed, 19 Aug 2026 09:00:00 -0400

Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the point of use.

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Wed, 19 Aug 2026 09:00:00 -0400

Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the point of use.

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Wed, 19 Aug 2026 09:00:00 -0400

Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the point of use.

Ainos reports 878M data points as AI Nose deployment grows

Thu, 13 Aug 2026 09:02:11 -0400

Ainos, Inc. (NASDAQ: AIMD, NASDAQ: AIMDW) announced its AI Nose platform has accumulated approximately 878 million chemical and smell data points, up from approximately 613 million reported on July 21, 2026, an increase of roughly 265 million data points in 23 days.

The company said the data is collected from semiconductor manufacturing environments through its network of deployed AI Nose systems, which it describes as Physical Edge Nodes. The data feeds into its ScentAI continuous learning architecture, which the company says supports chemical recognition, anomaly detection and trend analysis.

Ainos said it continues to advance a planned deployment of 1,400 AI Nose